Division of
Gastroenterology
and Hepatology

Hepatology Faculty

Click the names below to view each person's bio.

James "Jay" R. Burton, Jr., MD

Gregory T. Everson, MD, FACP

Lisa M. Forman, MD, MSCE

Hugo R. Rosen, MD, FACP

James F. Trotter, MD

 

Education

• Medical School: Emory University School of Medicine, Atlanta, GA, MD, 1989
• Internship/Residency:
  • University of Texas Southwestern Medical Center-Dallas
  • Parkland Hospital, Dallas, TX, 1989 - 1992
• Fellowship:
  • Gastroenterology, Duke University Medical Center, 1992 - 1995
  • Hepatic Transplantation, Duke University Medical Center, 1996
• Board Certified in Internal Medicine and Gastroenterology

Honors and Awards

• Co-investigator, "The effects of moderately elevated plasma phenylalanine on brain function, "Division of Medical Genetics, Emory University School of Medicine, 1986., $1500
• Co-investigator , "The effect of diabetes on an hepatic system that inactivates tyrosine aminotransferase," Department of Cell Biology, Emory University, 1987, $1800
• Judges' Award for "The effect of diabetes on the enzymatic formation of persulfides from sulfur amino acids: novel metabolites with pathogenetic implications," Medical Student Research Day, Emory University, 1987.
• Investigator, "Transforming growth factor-beta signal transduction in hepatic fibrosis," in the laboratory of David Brenner, Division of Gastroenterology, University of North Carolina-Chapel Hill, 1993-96, funded through Physician Scientist Award, National Institutes of Health, 5-K12-DK-01965-04, 1993-98, $250,000
• Participating investigator, Veterans Affairs Medical Center Multicenter Trial, "Effects of polyunsaturated lecithin on liver fibrosis," 1996-1999.
• Grant reviewer, National Institutes of Health, RFA 04-003 "Clinical Trials in Organ Transplantation," June 2004.

Faculty Appointments

• Associate, Department of Medicine, Duke University Medical Center, 1996-97
• Assistant Professor, Department of Medicine, Duke University Medical Center, 1997-1999
• Assistant Professor, Department of Medicine, University of Colorado Denver, 1999-2002
• Associate Professor, Department of Medicine, University of Colorado Denver, 2002-present

Representative Publications

1. Kugelmas M, Spiegelman P, Osgood MJ, Young DA, Trotter JF, et al. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl. 2003;9:727-32. (download PDF)
2. Hayashi PH, Ludkowski M, Forman LM, Osgood M, Johnson S, Kugelmas M, Trotter JF, et al. Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation. Am J Transplant. 2004;4:782-7. (download PDF)
3. Hayashi PH, Trotter JF. Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD. Liver Transpl 2004;10:42-8. (download PDF)
4. JF Trotter, M Osgood. MELD scores of liver transplant recipients according to size of waiting list: impact on organ allocation and patient outcomes. JAMA 2004;291:1871-4. (download PDF)
5. Trotter JF, Brimhall B, Arjal R. Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation.Liver Transpl;2004: 995-1000. (download PDF)
6. Trotter JF, Osborne JC, Heller M, Christians U. Effect of hepatitis C on tacrolimus dose and blood levels in liver transplant recipients with hepatitis C. Aliment Pharmacol Ther 2005;22:37-44. (download PDF)
7. JF Trotter, Pieramici E, Everson GT. Chronic albumin infusions to achieve diuresis in patients with ascites who are not candidates for transjugular intrahepatic portosystemic shunt (TIPS). Dig Dis Sci. 2005;50:1356-60. (download PDF)
8. Everson GT, Trotter J, Forman L, Kugelmas M, Halprin A, Fey B, Ray C. Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology. 2005 Aug;42(2):255-62. (download PDF)